Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Healthy Volunteers × eltrombopag × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thrombocytopenia 14 Leukemia, Myeloid, Acute 11 Leukemia 7 Myelodysplastic Syndromes 5 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Jacobs syndrome 3 Sarcoma 2 Purpura, Thrombocytopenic, Idiopathic 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Hematologic Neoplasms 2 Congenital Abnormalities 2 Solid Tumor, Childhood 1 Recurrence 1 Primary Myelofibrosis 1 Pathologic Complete Response 1 Osteosarcoma 1 Neoplasms, Connective and Soft Tissue 1 Myeloproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

Rosuvastatin Calcium 2 technetium 99m HYNIC-duramycin 1 eltrombopag 1 darolutamide 1 Magnetic Iron Oxide Nanoparticles 1 Gelatin 1 Decision Support Techniques 1 Contrast Media 1 Cell Death 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04542382 2025-03-30

BCRPmarker

University of California, San Francisco

Phase 1 Completed

Healthy Volunteers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡